Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2008
08/28/2008US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies
08/28/2008US20080207500 Propiomelanocortin and corticotropin releasing factor peptide; therapy for cancer, multiple sclerosis, nervous system disorders
08/28/2008US20080207498 Methods for Treating Alzheimer's Disease
08/28/2008US20080207492 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders
08/28/2008US20080206335 Inert non-pareil core, fluvoxamine layer over core, rate-controlling membrane coating; fluvoxamine released over a period of 12 hours or more; once-daily oral administration
08/28/2008US20080206333 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
08/28/2008US20080206332 Tablet of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl)butanoic acid or a pharmaceutically acceptable salt; polyvinyl acetate phthalate release rate modifying polymer; hydroxypropylmethyl cellulose polymer; neuropathies
08/28/2008US20080206267 Inactivation Of Genes Of The Mep Pathway
08/28/2008US20080206255 Antibody cancer immunotherapy
08/28/2008US20080206253 inhibitor of p38 beta MAP kinase; interfering RNA, short hairpin RNA, ribozyme, antisense oligonucleotide, or protein inhibitor; monoclonal antibody, a polyclonal antibody, a peptide, or a small molecule
08/28/2008US20080206251 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases
08/28/2008US20080206241 rheumatoid arthritis; e.g., a GM-CSF antibody, and an anti-folate compounds, e.g., methotrexate; but in an amount that does not induce neutropenia
08/28/2008US20080206224 Muscle contraction treatment utilizing botulinum toxin
08/28/2008US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord
08/28/2008US20080206206 Bone marrow-derived neuronal cells
08/28/2008US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses
08/28/2008US20080206157 Using NO source like nitrosoguanidine, glycerol trinitrate, isoamyl nitrite; cerebral disorders;
08/28/2008US20080206146 Capable of crossing the blood brain barrier and having differential affinity for a tissue in the brain, such as diseased tissue; diagnosis; drug screening with animal model
08/28/2008DE102007009401A1 Synergist effective during tauopathy comprises 1-aza-9-oxafluorene compound
08/28/2008DE102007009319A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
08/28/2008DE102007009264A1 New 9-alkyl-beta-carboline compounds are dopamine receptor stimulators useful to treat and/or prevent movement disorder, Alzheimer's disease, Parkinson's disease and Wilson's diseases, and as additives for accelerating cell growth
08/28/2008DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves
08/28/2008CA2679921A1 Use of epimedium flavanoide and effective ingredient thereof for preparation of a medicament for promoting proliferation and differentiation of neural cells
08/28/2008CA2679173A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2679166A1 Spirocyclic cyclohexane derivatives
08/28/2008CA2678963A1 Prevention and treatment of synucleinopathic and amyloidogenic disease
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2678757A1 Ameliorating agent for insulin resistance
08/28/2008CA2678146A1 Compounds of formula (i) as serine protease inhibitors
08/28/2008CA2677582A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction
08/28/2008CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008CA2674300A1 Process for the production of high-purity 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef] [2] benzazepine and derivatives thereof
08/28/2008CA2652074A1 Substituted carboxamides as group 1 metabotropic receptor antagonists
08/27/2008EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders
08/27/2008EP1961756A1 Novel bisboron compound
08/27/2008EP1961754A1 Bicyclic heterocyclic compound
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1961745A1 Bicyclic heterocyclic compound
08/27/2008EP1961742A1 compounds of formula (I) as serine protease inhibitors
08/27/2008EP1961738A1 New compounds with antiglutamatergic properties and uses thereof
08/27/2008EP1961447A2 Treating depressive disorders with PKC activators
08/27/2008EP1960428A1 Antibodies against amyloid beta 4 with glycosylated in the variable region
08/27/2008EP1960401A1 Tricyclic amide derivatives useful for treating obesity
08/27/2008EP1960392A2 Heterocycle-substituted 3-alkyl azetidine derivatives
08/27/2008EP1960389A2 Compounds which have activity at m1 receptor and their uses in medicine
08/27/2008EP1960387A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
08/27/2008EP1960373A2 Novel quinoxaline derivatives and their medical use
08/27/2008EP1960372A1 Kinase inhibitors and their uses
08/27/2008EP1960360A1 Azetidine derivatives as glyt1 inhibitors
08/27/2008EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/27/2008EP1959991A2 Therapeutic vaccine
08/27/2008EP1959980A2 Treatment of neurodegenerative disorders
08/27/2008EP1959973A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
08/27/2008EP1959969A2 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
08/27/2008EP1959954A2 Compositions and methods for treating cns disorders
08/27/2008EP1959946A2 Methods of treating ischemic related conditions
08/27/2008EP1959944A1 A pharmaceutical composition comprising an amide derivative
08/27/2008EP1959921A2 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer
08/27/2008EP1751144B1 Constrained himbacine analogs as thrombin receptor antagonists
08/27/2008EP1716145B1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/27/2008EP1697318B1 Prolinylarylacetamides
08/27/2008EP1654255B1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors
08/27/2008EP1531814B1 Sustained-release tablet composition of pramipexole
08/27/2008EP1526850B1 Use of vitamin C for the treatment of Charcot-Marie-Tooth disease
08/27/2008EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
08/27/2008EP1406895B1 Lactone formulations and method of use
08/27/2008EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
08/27/2008EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B
08/27/2008EP1089994B9 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
08/27/2008CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists
08/27/2008CN101252935A Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
08/27/2008CN101252932A Trazodone composition for once a day administration
08/27/2008CN101250508A Queen gel clastic enzyme composition
08/27/2008CN101249252A Traditional Chinese medicine preparation for curing epilepsy disease
08/27/2008CN101249246A Proprietary Chinese medicine preparations for curing depression after cerebral infarction
08/27/2008CN101249236A Chinese and western medicinalcombine preparations for curing epileptic
08/27/2008CN101249226A Traditional Chinese medicine preparation for curing madness disease
08/27/2008CN101249225A Traditional chinese medicine preparation for curing madnessdisease
08/27/2008CN101249222A Traditional Chinese medicine preparation for curing neurasthenic
08/27/2008CN101249219A Paste for curing idiopathic facial nerve paralysis disease and preparation method thereof
08/27/2008CN101249210A Relieving mental stress capsules
08/27/2008CN101249154A Nourishing blood soothe the nerves oral liquid
08/27/2008CN101249130A Medicinal or health care combination for stop smoking or alleviating stop smoking syndrome
08/27/2008CN101249125A Herbicide composition and its preparation and application, medicament use
08/27/2008CN101249124A Pharmaceutical combination and medicament use thereof
08/27/2008CN101249123A Chinese medicine injection and method of preparing the same and medicament use
08/27/2008CN101249118A Chinese medicine extract and medicine use thereof
08/27/2008CN101249101A Applications of human placenta interstitial fluid for curing brain and cerebrovascular disease medicament
08/27/2008CN101249091A Target for therapy of cognitive impairment
08/27/2008CN101249090A Target for theraphy of cognitive impairment
08/27/2008CN101248897A Method for preparing sobering-up drink
08/27/2008CN100413885C Modified proteins, designer toxins and methosd of making thereof
08/27/2008CN100413883C Peptidic compounds selectively binding to p-selectin
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413877C Helicid modifier and its preparation method and uses
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
1 ... 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 ... 1833